About The Hospital

St. Stamford Modern Cancer Hospital Guangzhou

No.42, Lianquan Road, Central Business East, Tianhe District, Guangzhou City, China

St. Stamford Modern Cancer Hospital Guangzhou is a leading international hospital specializing in oncology, integrating minimally invasive technologies with traditional Chinese and Western medicine. It is jointly invested by China and Singapore, and is under the management of the Boai Medical Group, the largest hospital chain in China.

This hospital holds JCI (Joint Commission International) accreditation, affirming its global medical service standards. With modern architecture, comprehensive diagnostic and therapeutic equipment, and an international multilingual medical team, the hospital ensures personalized and advanced cancer care. Facilities include advanced interventional radiology suites, precise minimally invasive surgical theaters, and comfortable VIP wards designed to meet international patients' expectations.

It receives patients not only from China but also across Southeast Asia, the Middle East, and Africa, positioning itself as a preferred destination for international medical tourists seeking oncology treatment excellence.

Medical Travel Services:

Multilingual support (English, Chinese, Vietnamese, Thai, Arabic, etc.)
Airport pick-up/drop-off
Personal interpreter and medical guidance services
International outpatient and inpatient service system
Custom treatment plans for overseas patients
Collaboration with overseas medical referral partners

Achievements:

Accredited by Joint Commission International (JCI)
First hospital in China invested by Singapore’s Stamford International Medical Group
Pioneering 18 minimally invasive cancer treatment technologies
Recognized as a preferred cancer treatment hub in Southeast Asia
Collaboration with leading international insurance providers

Team & Specialisation

Focused on oncology treatments, with a multidisciplinary care model
International medical specialists with experience from Germany, Japan, South Korea, and China
Language-diverse staff for seamless communication with foreign patients
Emphasis on interventional therapy, targeted therapy, and immunotherapy